Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Evotec SE
  6. Summary
    EVT   DE0005664809

EVOTEC SE

(EVT)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
06/08/2021 06/09/2021 06/10/2021 06/11/2021 06/14/2021 Date
34.69(c) 34.72(c) 34.94(c) 35.33(c) 35.92 Last
464 408 356 336 315 098 329 151 51 154 Volume
-0.40% +0.09% +0.63% +1.12% +1.67% Change
More quotes
Financials
Sales 2021 557 M 674 M 674 M
Net income 2021 46,3 M 56,0 M 56,0 M
Net Debt 2021 60,5 M 73,2 M 73,2 M
P/E ratio 2021 132x
Yield 2021 -
Sales 2022 646 M 782 M 782 M
Net income 2022 44,0 M 53,3 M 53,3 M
Net Debt 2022 89,0 M 108 M 108 M
P/E ratio 2022 127x
Yield 2022 -
Capitalization 5 782 M 6 994 M 6 999 M
EV / Sales 2021 10,5x
EV / Sales 2022 9,09x
Nbr of Employees 3 735
Free-Float 84,1%
More Financials
Company
Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug... 
Sector
Biotechnology & Medical Research
Calendar
06/15 | 04:00amShareholder meeting
More about the company
Ratings of Evotec SE
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about EVOTEC SE
04:11aEVOTEC  : partners with CEBINA to launch Danube Labs, a partnership to develop c..
PU
06/07EVOTEC  : Autobahn Labs incubator announces partnership with Cold Spring Harbor ..
PU
06/01EVOTEC SE : Release according to Article 40, Section 1 of the WpHG [the German S..
EQ
05/31EVOTEC SE : Release according to Article 41 of the WpHG [the German Securities T..
EQ
05/25DGAP-PVR  : Evotec SE: Release according to Article 40, Section 1 of the WpHG [t..
DJ
05/25EVOTEC SE : Release according to Article 40, Section 1 of the WpHG [the German S..
EQ
05/19EVOTEC  : RBC reaffirms its Buy rating
MD
05/12EVOTEC  : Deutsche Bank sticks Neutral
MD
05/11EVOTEC  : Receives a Buy rating from Warburg Research
MD
05/11EVOTEC  : Baader Bank reaffirms its Buy rating
MD
05/11EVOTEC  : RBC takes a positive view
MD
05/11EVOTEC  : reports results for the first quarter 2021 and provides corporate upda..
PU
05/11PRESS RELEASE : Evotec se reports results for the -2-
DJ
05/11PRESS RELEASE : Evotec se reports results for the first quarter 2021 and provide..
DJ
05/11EVOTEC  : Reports results for the first quarter 2021 and provides corporate upda..
EQ
More news
News in other languages on EVOTEC SE
12:06aWOCHENVORSCHAU : Termine bis 25. Juni 2021
06/11WOCHENVORSCHAU : Termine bis 25. Juni 2021
06/11WOCHENVORSCHAU : Termine bis 24. Juni 2021
06/10WOCHENVORSCHAU : Termine bis 23. Juni 2021
06/09WOCHENVORSCHAU : Termine bis 22. Juni 2021
More news
Analyst Recommendations on EVOTEC SE
More recommendations
Stock Trading Strategies
EVOTEC SE - 2020
Back on price levels to sell
SELL
More Stock Trading Analysis
Chart EVOTEC SE
Duration : Period :
Evotec SE Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EVOTEC SE
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 9
Average target price 34,61 €
Last Close Price 35,33 €
Spread / Highest target 13,2%
Spread / Average Target -2,03%
Spread / Lowest Target -16,5%
EPS Revisions
Managers and Directors
NameTitle
Werner Lanthaler Chief Executive Officer
Enno Spillner Chief Financial Officer
Wolfgang Plischke Chairman-Supervisory Board
Cord E. Dohrmann Chief Scientific Officer
Craig L. Johnstone Chief Operating Officer & Member-Management Board
Sector and Competitors
1st jan.Capitalization (M$)
EVOTEC SE16.68%6 994
MODERNA, INC.109.49%87 874
LONZA GROUP AG16.32%54 656
IQVIA HOLDINGS INC.35.87%46 658
CELLTRION, INC.-26.04%32 458
SEAGEN INC.-10.60%28 416